Development and implementation of pharmaceutical care planning software for nursing homes based on the Fleetwood model

American Journal of Health-System Pharmacy

Volumn 63, Issue 24, 2006, Pages 2483-2487

  Lapane, Kate L ^a,e   Hiris, Jeffrey ^b   Hughes, Carmel M ^c   Feinberg, Janice ^d  

^a Department of Community Health ^*  (United States)

^b BROWN UNIVERSITY   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d American Society of Consultant Pharmacists Foundation   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Computers; Drug use; Interventions; Methodology; Models; Nursing homes; Pharmaceutical care; Pharmaceutical services; Pharmacists

Indexed keywords

ARTICLE; COMPUTER PROGRAM; COOPERATION; DOCUMENTATION; EVALUATION; FEASIBILITY STUDY; FLEETWOOD MODEL; HOSPITAL READMISSION; HUMAN; INTERPERSONAL COMMUNICATION; NORMAL HUMAN; NURSING HOME; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROCESS MODEL; SELF REPORT; TREATMENT PLANNING;

EID: 33847781956     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050528     Document Type: Article

References (14)

1. Bernabei R, Gambassi G, Lapane KL et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol Biol Sci Med Sci. 1999; 54:M25-33.
2. Lamy PP. Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy. Drugs Aging. 1991; 5:385-404.
3. Hanlon JT, Schmader KE, Ruby CM et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001; 49:200-9.
4. Gurwitz JH, Field TS, Avorn J et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000; 109:87-94.
5. Rhoades J. Nursing homes-structure and selected characteristics, 1987 and 1996. Stat Bull Metrop Insur Co. 1998; 79:2-9.
6. Omnibus Budget Reconciliation Act of 1987, Pub. L. N. 100-203.
7. Cameron KA, Feinberg JL, Lapane KL. Fleetwood Project Phase III moves forward. Consult Pharm. 2002; 17:180-200.
8. Lapane KL, Hughes CM Identifying nursing home residents at high-risk for preventable adverse drug events: modifying a tool for use in the Fleetwood Phase III study. Consult Pharm. 2004; 19:533-7.
9. Christian JB, vanHaaren A, Cameron K et al. Alternatives of potentially inappropriate medications in the elderly population: treatment algorithms for use in the Fleetwood Phase III study. Consult Pharm. 2004; 19:1011-28.
10. Lapane KL, Hughes CM. Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase III study: the role of process control. Ann Pharmacother. 2006; 40:1522-6.
11. Kuel AK, Chrischilles EA, Sorofman BA. System for exchanging information among pharmacists in different practice environments. Am J Health-Syst Pharm. 1998; 55:1017-24.
12. Bradley EH, Webster TR, Baker D et al. Translating research into practice: speeding the adoption of innovative health care programs. Issues Brief (Commonwealth Fund). 2004; 724:1-12.
13. Weinberger M, Murray MD, Marrero DG et al. Effectiveness of pharmacist care for patients with reactive airways disease. JAMA. 2002; 288:1594-1602.
14. University of Minnesota. Assurance pharmaceutical care documentation software. www.pharmacy.umn.edu/centers/peters/ assurance/home.htl (accessed 2006 Oct 2).